Abbott laboratories
ABT 投資分析
看多重點：
- 價值≥4
- 股利≥2
分析結論
價值面評分優異，股利評分名列前茅，值得長期累積部位。若想獲得較好的進場時機，可參考技術面趨勢與波段評分
ABT 近期報酬表現
-2.10%
Abbott laboratories
-2.56%
同產業平均
-1.46%
S&P500
與 ABT 同產業的標的表現
| 股票代碼 | 公司名稱 | 價值 | 趨勢 | 波段 | 籌碼 | 股利 | 加入追蹤 |
|---|---|---|---|---|---|---|---|
TMO | Thermo fisher scientific inc. | 3 分 | 5 分 | 1 分 | 3 分 | 3 分 | |
LH | Laboratory corporation of america holdings | 2 分 | 1 分 | 2 分 | 2 分 | 1 分 | |
IDXX | Idexx laboratories incorporated | 4 分 | 3 分 | 2 分 | 2 分 | 1 分 | |
DHR | Danaher corp | 5 分 | 3 分 | 2 分 | 3 分 | 3 分 | |
A | Agilent technologies, inc. | 5 分 | 4 分 | 2 分 | 3 分 | 3 分 |
- TMO Thermo fisher scientific inc.價值 3 分趨勢 5 分波段 1 分籌碼 3 分股利 3 分查看更多
ABT 公司資訊
Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. The Diagnostic Products segment is engaged in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment is involved in the worldwide sales of a broad line of adult and pediatric nutritional products. The Medical Devices segment includes the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.